ATE471941T1 - Verfahren zur herstellung von thiazolopyrimidinen - Google Patents

Verfahren zur herstellung von thiazolopyrimidinen

Info

Publication number
ATE471941T1
ATE471941T1 AT04801262T AT04801262T ATE471941T1 AT E471941 T1 ATE471941 T1 AT E471941T1 AT 04801262 T AT04801262 T AT 04801262T AT 04801262 T AT04801262 T AT 04801262T AT E471941 T1 ATE471941 T1 AT E471941T1
Authority
AT
Austria
Prior art keywords
thiazolopyrimidines
producing
producing thiazolopyrimidines
Prior art date
Application number
AT04801262T
Other languages
German (de)
English (en)
Inventor
Michael Butters
Richard Wisedale
Colin Thomson
Matthew Welham
Andrew Watts
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of ATE471941T1 publication Critical patent/ATE471941T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D497/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D497/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D497/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT04801262T 2003-12-05 2004-12-02 Verfahren zur herstellung von thiazolopyrimidinen ATE471941T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0328243.1A GB0328243D0 (en) 2003-12-05 2003-12-05 Methods
PCT/GB2004/005072 WO2005056563A2 (en) 2003-12-05 2004-12-02 Process for the preparation of thiazolopyrimidines

Publications (1)

Publication Number Publication Date
ATE471941T1 true ATE471941T1 (de) 2010-07-15

Family

ID=29764654

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04801262T ATE471941T1 (de) 2003-12-05 2004-12-02 Verfahren zur herstellung von thiazolopyrimidinen

Country Status (22)

Country Link
US (3) US7790883B2 (enExample)
EP (1) EP1711505B1 (enExample)
JP (1) JP4808629B2 (enExample)
KR (1) KR101170188B1 (enExample)
CN (1) CN1914213B (enExample)
AR (1) AR046750A1 (enExample)
AT (1) ATE471941T1 (enExample)
AU (1) AU2004296241B2 (enExample)
BR (1) BRPI0417300A (enExample)
CA (1) CA2546719A1 (enExample)
DE (1) DE602004027840D1 (enExample)
ES (1) ES2345660T3 (enExample)
GB (1) GB0328243D0 (enExample)
IL (1) IL175743A (enExample)
MY (1) MY143761A (enExample)
NO (1) NO20063111L (enExample)
NZ (2) NZ583012A (enExample)
SG (1) SG149005A1 (enExample)
TW (1) TWI347945B (enExample)
UY (1) UY28651A1 (enExample)
WO (1) WO2005056563A2 (enExample)
ZA (1) ZA200604491B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9903544D0 (sv) 1999-10-01 1999-10-01 Astra Pharma Prod Novel compounds
GB2359551A (en) * 2000-02-23 2001-08-29 Astrazeneca Uk Ltd Pharmaceutically active pyrimidine derivatives
SE0102716D0 (sv) * 2001-08-14 2001-08-14 Astrazeneca Ab Novel compounds
GB0221828D0 (en) * 2002-09-20 2002-10-30 Astrazeneca Ab Novel compound
GB0221829D0 (en) * 2002-09-20 2002-10-30 Astrazeneca Ab Novel compound
GB0328243D0 (en) 2003-12-05 2004-01-07 Astrazeneca Ab Methods
DK3054936T5 (da) 2013-10-10 2024-03-18 Eastern Virginia Medical School 4-((2-hydroxy-3-methoxybenzyl)amino) benzensulfonamid derivater som 12-lipoxygenase inhibitorer
GB201807898D0 (en) * 2018-05-15 2018-06-27 Kancera Ab New processes and products with increased chiral purity

Family Cites Families (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2924472A (en) 1957-06-27 1960-02-09 Gen Motors Corp Pipe joint seal
US3182062A (en) 1962-02-28 1965-05-04 Smith Kline French Lab Synthesis of quinoxalines and analogues thereof
GB1009477A (en) 1962-02-13 1965-11-10 Smith Kline French Lab Novel process for preparing heterocyclic compounds
US3318900A (en) 1964-05-06 1967-05-09 Janssen Pharmaceutica Nv Derivatives of benzimidazolinyl piperidine
BE668603A (enExample) 1964-08-20
DE2331223C2 (de) 1972-06-19 1984-11-22 Kohjin Co., Ltd., Tokio / Tokyo S-substituierte-2-Thioadenosine, deren 5'-Monophosphate, Verfahren zu deren Herstellung und Arzneimittel, welche diese enthalten
JPS5188994A (en) 1975-02-04 1976-08-04 Shinkijichikan 88 aminoadeninjudotainoseizoho
US4120521A (en) 1975-08-28 1978-10-17 Rieber & Son Plastic-Industri A/S Combined mould element and sealing ring
EG12406A (en) 1976-08-12 1979-03-31 Janssen Pharmaceutica Nv Process for preparing of novel n-aryl-n-(1-l-4-piperidinyl)-arylacetamides
GB1600293A (en) 1977-02-04 1981-10-14 British Oceanics Ltd Sealing arrangements
US4188040A (en) 1977-04-06 1980-02-12 Firma WOCO Franz-Josef Wolf & Co. Sealing ring
DE2726959A1 (de) 1977-06-15 1979-01-18 Arlt Christian Dichteinsatz zum dichten verbinden von zwei rohren
FR2421899A1 (fr) 1978-01-16 1979-11-02 Roussel Uclaf Nouveaux derives du tetrahydropyridinyl-indole et leurs sels, le procede de preparation et l'application a titre de medicaments de ces nouveaux produits
US4410528A (en) 1980-05-16 1983-10-18 Kyowa Hakko Kogyo Co., Ltd. Hypotensive piperidine derivatives
DE3219522A1 (de) 1981-10-28 1983-12-01 Denso-Chemie Wedekind Kg, 5090 Leverkusen Steckmuffendichtung fuer rohre
FR2547888B1 (fr) 1983-06-22 1985-12-13 Sabla Sa Bague d'etancheite a implants pour tuyaux a emboitement
CA1338012C (en) 1987-04-27 1996-01-30 John Michael Mccall Pharmaceutically active amines
SE8800348L (sv) 1988-02-03 1989-08-04 Forsheda Ab Taetningsring och verktyg foer framstaellning daerav
FR2659656B1 (fr) 1990-03-15 1994-09-09 Sanofi Sa Derives de pyrimidinedione-2,4 et medicaments les contenant.
DE4119767A1 (de) 1991-06-15 1992-12-17 Dresden Arzneimittel Verfahren zur herstellung von (pyrimid-2-yl-thio- bzw. seleno)-essigsaeurederivaten
US5169161A (en) 1991-09-19 1992-12-08 Hail Mary Rubber Co., Inc. Symmetrical gasket for pipe joints
DE4134089C2 (de) 1991-10-15 1994-10-13 Dueker Eisenwerk Schubgesicherte Muffenverbindung
DE4229609C2 (de) 1992-09-04 2003-05-08 Forsheda Stefa Gmbh Abdichtung zwischen zwei ineinandersteckbaren Teilen
US5521197A (en) 1994-12-01 1996-05-28 Eli Lilly And Company 3-<1-alkylenearyl>-4-<1,2,3,6-tetrahydropyridinyl>-and 3-<1-alkylenearyl>-4-piperidinyl-1h-indoles: new 5-HT1F agonists
DE69628804T2 (de) 1995-12-08 2003-12-18 Pfizer Inc., New York Substitutierte heterozyclische Derivate als CRF Antagonisten
GB9624482D0 (en) 1995-12-18 1997-01-15 Zeneca Phaema S A Chemical compounds
SE515033C2 (sv) 1995-12-27 2001-06-05 Forsheda Ab Tätningsanordning
JP4471404B2 (ja) 1996-02-13 2010-06-02 アストラゼネカ ユーケイ リミテッド Ｖｅｇｆインヒビターとしてのキナゾリン誘導体
KR100489174B1 (ko) 1996-03-05 2005-09-30 제네카-파마 소시에떼아노님 4-아닐리노퀴나졸린유도체
AU2388697A (en) 1996-04-19 1997-11-12 Neurosearch A/S 1-(4-piperidyl)-benzimidazoles having neurotrophic activity
JP3621706B2 (ja) 1996-08-28 2005-02-16 ファイザー・インク 置換された６，５―ヘテロ―二環式誘導体
GB9718972D0 (en) 1996-09-25 1997-11-12 Zeneca Ltd Chemical compounds
AU5522498A (en) 1996-12-13 1998-07-03 Merck & Co., Inc. Substituted aryl piperazines as modulators of chemokine receptor activity
GB9714249D0 (en) 1997-07-08 1997-09-10 Angiogene Pharm Ltd Vascular damaging agents
AU8576098A (en) 1997-07-25 1999-02-16 Merck & Co., Inc. Cyclic amine modulators of chemokine receptor activity
AR013669A1 (es) 1997-10-07 2001-01-10 Smithkline Beecham Corp Compuestos y metodos
AU732361B2 (en) 1997-11-28 2001-04-26 Dainippon Sumitomo Pharma Co., Ltd. Novel heterocyclic compounds
JP3342478B2 (ja) 1998-01-19 2002-11-11 ファイザー製薬株式会社 Ｏｒｌ１−レセプターアゴニストとしての４−（２−ケト−１−ベンズイミダゾリニル）ピペリジン化合物
CA2324550A1 (en) 1998-03-19 1999-09-23 Shigeyuki Chaki Arylpiperidine derivatives and use thereof
WO1999051608A1 (en) 1998-04-03 1999-10-14 Du Pont Pharmaceuticals Company THIAZOLO[4,5-d]PYRIMIDINES AND PYRIDINES AS CORTICOTROPIN RELEASING FACTOR (CRF) ANTAGONISTS
MA26659A1 (fr) 1998-08-06 2004-12-20 Pfizer Dérivés de benzimidazole nouveaux, compositions pharmaceutiques les contenant et procédé pour leur préparation.
SE9802729D0 (sv) 1998-08-13 1998-08-13 Astra Pharma Prod Novel Compounds
US5988695A (en) 1998-08-26 1999-11-23 S&B Technical Products, Inc. Pipe gasket with embedded ring
PE20001420A1 (es) 1998-12-23 2000-12-18 Pfizer Moduladores de ccr5
ATE277929T1 (de) 1998-12-28 2004-10-15 4 Aza Bioscience Nv Immunsuppressive wirkungen von pteridinderivaten
GB9900334D0 (en) 1999-01-07 1999-02-24 Angiogene Pharm Ltd Tricylic vascular damaging agents
GB9900752D0 (en) 1999-01-15 1999-03-03 Angiogene Pharm Ltd Benzimidazole vascular damaging agents
EP1187615A2 (en) 1999-02-02 2002-03-20 K.U. Leuven Research & Development Immunosurpressive effects of pteridine derivatives
US6248755B1 (en) 1999-04-06 2001-06-19 Merck & Co., Inc. Pyrrolidine modulators of chemokine receptor activity
US6142484A (en) 1999-04-15 2000-11-07 Vassallo Research & Development Corporation Composite multi-pressure gasket
AU5600100A (en) 1999-06-11 2001-01-02 Merck & Co., Inc. Cyclopentyl modulators of chemokine receptor activity
US6340681B1 (en) 1999-07-16 2002-01-22 Pfizer Inc 2-benzimidazolylamine compounds as ORL-1-receptor agonists
EE200200140A (et) 1999-09-15 2003-04-15 Warner-Lambert Company Pteridinoonid kui kinaasi inhibiitorid
SE9903544D0 (sv) * 1999-10-01 1999-10-01 Astra Pharma Prod Novel compounds
AR025884A1 (es) 1999-10-01 2002-12-18 Takeda Pharmaceutical Compuestos de amina ciclica, su produccion y su uso
ES2249237T3 (es) 2000-01-05 2006-04-01 Pfizer Inc. Compuestos de bencimidazol como antagonistas del receptor orl1.
GB2359081A (en) 2000-02-11 2001-08-15 Astrazeneca Uk Ltd Pharmaceutically active thiazolopyrimidines
WO2001058906A1 (en) 2000-02-11 2001-08-16 Astrazeneca Ab Pyrimidine compounds and their use as modulators of chemokine receptor activity
GB2359079A (en) 2000-02-11 2001-08-15 Astrazeneca Uk Ltd Pharmaceutically active pyrimidine derivatives
GB2359078A (en) 2000-02-11 2001-08-15 Astrazeneca Uk Ltd Pharmaceutically active pyrimidine derivatives
GB2359551A (en) 2000-02-23 2001-08-29 Astrazeneca Uk Ltd Pharmaceutically active pyrimidine derivatives
GB0005642D0 (en) 2000-03-10 2000-05-03 Astrazeneca Uk Ltd Chemical compounds
WO2001070689A1 (en) 2000-03-24 2001-09-27 Meiji Seika Kaisha, Ltd. DIPHENYLALKYLAMINE DERIVATIVES USEFUL AS OPIOID δ RECEPTOR AGONISTS
AU2001258628A1 (en) 2000-05-31 2001-12-11 Astrazeneca Ab Indole derivatives with vascular damaging activity
JP2004504391A (ja) 2000-07-07 2004-02-12 アンギオジェン・ファーマシューティカルズ・リミテッド 血管新生阻害剤としてのコルキノール誘導体
NZ522861A (en) 2000-07-07 2004-07-30 Angiogene Pharm Ltd Colchinol derivatives as vascular damaging agents
SE0003828D0 (sv) 2000-10-20 2000-10-20 Astrazeneca Ab Novel compounds
SE0004110L (sv) 2000-11-10 2002-05-11 Forsheda Ab Tätningsring
SE0101322D0 (sv) 2001-04-12 2001-04-12 Astrazeneca Ab Novel compounds
SE0102716D0 (sv) 2001-08-14 2001-08-14 Astrazeneca Ab Novel compounds
GB0221829D0 (en) 2002-09-20 2002-10-30 Astrazeneca Ab Novel compound
GB0221828D0 (en) 2002-09-20 2002-10-30 Astrazeneca Ab Novel compound
US20070142386A1 (en) 2003-10-07 2007-06-21 Astrazeneca New 2-substituted, 4-amino-thiazolo[4,5-d] pyrimidines, useful as chemokine receptor antagonists, esp. cx3cr1
GB0328243D0 (en) 2003-12-05 2004-01-07 Astrazeneca Ab Methods
WO2005082865A1 (ja) 2004-02-27 2005-09-09 Astellas Pharma Inc. 縮合二環性ピリミジン誘導体
US20090239882A1 (en) 2004-12-17 2009-09-24 Astrazeneca Ab Thiazolopyramidine Compounds for the Modulation of Chemokine Receptor Activity

Also Published As

Publication number Publication date
SG149005A1 (en) 2009-01-29
CN1914213B (zh) 2011-05-11
TWI347945B (en) 2011-09-01
US20090043097A1 (en) 2009-02-12
BRPI0417300A (pt) 2007-03-06
US20070282103A1 (en) 2007-12-06
TW200524945A (en) 2005-08-01
NZ547685A (en) 2010-02-26
CA2546719A1 (en) 2005-06-23
AU2004296241B2 (en) 2009-01-22
US20100217000A1 (en) 2010-08-26
EP1711505B1 (en) 2010-06-23
UY28651A1 (es) 2005-07-29
IL175743A (en) 2011-10-31
WO2005056563A2 (en) 2005-06-23
US7790883B2 (en) 2010-09-07
WO2005056563A3 (en) 2005-08-25
JP4808629B2 (ja) 2011-11-02
AR046750A1 (es) 2005-12-21
AU2004296241A1 (en) 2005-06-23
DE602004027840D1 (de) 2010-08-05
ZA200604491B (en) 2007-10-31
GB0328243D0 (en) 2004-01-07
ES2345660T3 (es) 2010-09-29
CN1914213A (zh) 2007-02-14
NO20063111L (no) 2006-09-05
JP2007513131A (ja) 2007-05-24
KR20060118525A (ko) 2006-11-23
IL175743A0 (en) 2006-09-05
NZ583012A (en) 2011-08-26
KR101170188B1 (ko) 2012-07-31
EP1711505A2 (en) 2006-10-18
MY143761A (en) 2011-07-15

Similar Documents

Publication Publication Date Title
ATE408609T1 (de) Verfahren zur herstellung von n-phenylpyrazol-1- carboxamiden
ATE340819T1 (de) Verfahren zur herstellung von polyamiden
DE60221399D1 (de) Verfahren zur herstellung von mitteldistillaten
ATE403641T1 (de) Verfahren zur herstellung von o- desmethylvenlafaxin
ATE515500T1 (de) Verfahren zur herstellung von telmisartan
ATE440888T1 (de) Verfahren zur herstellung von glatiramer
DE602005019848D1 (de) Verfahren zur herstellung von tad- getrocknetem ti
ATA11912002A (de) Verfahren zur herstellung von fälschungssicheren identifikationsmerkmalen
DE60230908D1 (de) Verfahren zur herstellung von polyarylenethern
DE60327788D1 (de) Verfahren zur herstellung von polytrimethylenterephthalt-fasern
ATE308524T1 (de) Verfahren zur herstellung von aripiprazole
DE50308650D1 (de) Verfahren zur herstellung von cellulosecarbamatformkörpern
DE602004022134D1 (de) Verfahren zur herstellung von dinitrilen
ATE553103T1 (de) Verfahren zur herstellung von (s)-pantoprazol
ATE453619T1 (de) Verfahren zur herstellung von hydroperoxiden
ATE336478T1 (de) Verfahren zur herstellung von benzophenonen
DE50303611D1 (de) Verfahren zur herstellung von polyisobuten
DE502004004318D1 (de) Verfahren zur herstellung von metall-matrix-verbundwerkstoffen
DE50200870D1 (de) Verfahren zur herstellung von hydroxyalkylpolysiloxanen
ATE402138T1 (de) Verfahren zur herstellung von 2- aminoindanderivaten
ATE549314T1 (de) Verfahren zur herstellung von 4-aminochinazolinen
DE60336173D1 (de) Verfahren zur herstellung von vanadylpyrophosphat-katalysatoren
ATE471941T1 (de) Verfahren zur herstellung von thiazolopyrimidinen
ATE371642T1 (de) Verfahren zur herstellung von 3- methylthiopropanal
ATE458741T1 (de) Verfahren zur herstellung von phthalocyaninen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties